Ultragenyx Pharmaceutical
RARE
#4102
Rank
NZ$4.38 B
Marketcap
NZ$46.41
Share price
0.18%
Change (1 day)
-39.45%
Change (1 year)

Ultragenyx Pharmaceutical (RARE) - Net assets

Net assets on the balance sheet as of March 2025 : NZ$0.25 Billion

According to Ultragenyx Pharmaceutical's latest financial reports the company has NZ$0.25 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Ultragenyx Pharmaceutical - Net assets on balance sheet (from 2012 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$0.46 B6.79%
2023-12-31$NZ$0.43 B-21.56%
2022-12-31$NZ$0.55 B-58.89%
2021-12-31$NZ$1.35 B-15.58%
2020-12-31$NZ$1.59 B64.81%
2019-12-31$NZ$0.97 B6.94%
2018-12-31$NZ$0.90 B68.13%
2017-12-31$NZ$0.53 B-21.09%
2016-12-31$NZ$0.68 B-11.82%
2015-12-31$NZ$0.77 B228.74%
2014-12-31$NZ$0.23 B287.1%
2013-12-31$NZ$60.97 M-40.52%
2012-12-31$NZ$0.10 B651.81%
2011-12-31$NZ$13.63 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
BioMarin Pharmaceutical
BMRN
NZ$9.72 B 3,730.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.32 B 27.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-NZ$0.72 Billion-381.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
NZ$0.20 B-18.65%๐Ÿ‡บ๐Ÿ‡ธ USA